The Keller Postman Tylenol lawsuit update for 2026 shows a case that is still very much alive, with thousands of families waiting on a resolution that could change their financial futures. If you used Tylenol during pregnancy and your child was later diagnosed with autism or ADHD, this lawsuit directly affects you.
This guide covers everything happening in 2026: where the MDL stands, what the bellwether trial results mean, who qualifies, and what kind of payout families can realistically expect.
One fact worth knowing upfront: over 100,000 cases have been filed in MDL 3043, making this one of the largest pharmaceutical mass torts in American legal history. The case is far from over, and new developments this year are shifting the direction toward settlement talks.
Here is exactly what you need to know.
Keller Postman Tylenol Lawsuit Update 2026
The Keller Postman Tylenol lawsuit update for 2026 centers on continued litigation in MDL 3043, with settlement negotiations gaining real momentum after years of pretrial battles. Keller Postman, one of the lead plaintiffs’ firms in this case, is pushing aggressively for compensation on behalf of families whose children developed autism or ADHD after prenatal Tylenol exposure.
The firm has been one of the most active players in this MDL. They have filed tens of thousands of individual plaintiff cases. Their litigation strategy in 2026 is focused on leveraging bellwether trial outcomes to pressure defendants into a global settlement.
The biggest shift in 2026 is the tone of the negotiations. Defendants, including Johnson and Johnson and major retailers, are increasingly signaling openness to resolving cases without going through full jury trials.
| 2026 Case Status | Detail |
|---|---|
| MDL Docket | MDL 3043, S.D.N.Y. |
| Presiding Judge | Judge Denise Cote |
| Cases Filed | Approximately 100,000+ |
| Keller Postman Role | Lead plaintiffs’ counsel |
| Current Phase | Settlement negotiation and trial prep |
| Expected Resolution | Late 2026 to 2027 |
Families who have already filed with Keller Postman should be receiving updates through their case portals or direct attorney contact. If you have not filed yet, the window to join is still open but narrowing.
What Is the Keller Postman Tylenol Lawsuit?
The Keller Postman Tylenol lawsuit is a mass tort action alleging that acetaminophen, sold under the brand name Tylenol and numerous generic store brands, caused autism spectrum disorder and ADHD in children when mothers took the drug during pregnancy. Keller Postman is one of the primary law firms representing plaintiffs in this litigation.
The science behind the claim is not new. Multiple peer-reviewed studies, including research published in JAMA Pediatrics and backed by the National Institutes of Health, found associations between prolonged prenatal acetaminophen use and increased rates of neurodevelopmental disorders in children.
The legal argument is simple: manufacturers and retailers knew or should have known about this risk. They sold the product without adequate warnings to pregnant women.
| Lawsuit at a Glance | Detail |
|---|---|
| Product Involved | Tylenol (acetaminophen) |
| Alleged Harm | Autism Spectrum Disorder, ADHD |
| Exposure Period | Prenatal use during pregnancy |
| Type of Case | Mass tort / MDL (not class action) |
| Primary Defendants | Johnson and Johnson, major retailers |
| Lead Plaintiff Firm | Keller Postman |
Think of it like the talcum powder lawsuits that took down billions in J&J verdicts. Same playbook: a common product, a hidden risk, a corporate failure to warn, and thousands of families left to figure it out on their own.
What Is the Tylenol Autism Lawsuit?
The Tylenol autism lawsuit is a product liability case arguing that prenatal exposure to acetaminophen is causally linked to autism spectrum disorder (ASD) in children. It is not a single lawsuit but a collection of individual cases consolidated under MDL 3043 in federal court.
This distinction matters. Unlike a class action where all plaintiffs share one settlement equally, an MDL allows each plaintiff to pursue their own individual case. Your payout is based on your child’s specific diagnosis, the severity of their condition, and the evidence you can provide about your Tylenol use during pregnancy.
The scientific foundation of this lawsuit comes from decades of epidemiological research. A landmark 2019 study in JAMA Pediatrics followed 132,000 mother-child pairs and found that children with the highest prenatal acetaminophen exposure were significantly more likely to be diagnosed with ADHD or ASD.
| Research Highlight | Detail |
|---|---|
| Key Study | JAMA Pediatrics, 2019 |
| Sample Size | 132,000 mother-child pairs |
| Finding | Higher exposure linked to higher ASD and ADHD rates |
| Additional Support | NIH-funded studies, multiple European cohort studies |
| Defendant Counter | Disputed causation; challenged expert testimony |
The defendants have fought hard to exclude this science from court. In a major Daubert hearing, Judge Cote ruled on the admissibility of expert testimony, which shaped how this case evolved in 2024 and into 2026.
Key Takeaway: The Tylenol autism lawsuit is a massive individual-plaintiff MDL backed by real peer-reviewed science, and Keller Postman is one of the firms leading the charge for families who may qualify.
MDL 3043 Case Update 2026
MDL 3043 is the formal name for the Tylenol autism and ADHD mass tort consolidated in the Southern District of New York. As of 2026, the case is in a pivotal phase where the outcomes of early proceedings are reshaping the litigation path forward.
The MDL was established in 2022. Judge Denise Cote has presided over it since the beginning. In 2023, she issued a controversial ruling that excluded certain general causation experts under the Daubert standard. That ruling shook the case significantly.
The plaintiffs, including Keller Postman, appealed. The appellate proceedings and their outcomes have been central to the 2026 update.
| MDL 3043 Timeline | Key Event |
|---|---|
| 2022 | MDL 3043 established, S.D.N.Y. |
| 2023 | Daubert hearing; some expert testimony excluded |
| 2024 | Appeals filed; case strategy adjusted |
| 2025 | Appellate rulings shape new trial direction |
| 2026 | Active litigation; settlement discussions ongoing |
Despite the turbulence, the MDL is still active. Thousands of cases remain in the pipeline. The appellate decisions in 2025 gave some plaintiffs a clearer path to trial, which is exactly what’s driving defendants toward settlement conversations in 2026.
MDL 3043 Bellwether Trial Results 2026
Bellwether trials are the test cases that go first. They give both sides a realistic preview of how juries will react to the evidence, and their outcomes heavily influence settlement offers. In MDL 3043, the bellwether process has been one of the most closely watched developments of 2026.
Bellwether trials are like sending the first batter up to figure out what the pitcher is throwing. The results don’t bind anyone, but they set the tone for everything that follows.
The outcomes of these early trials in 2026 have given plaintiffs’ attorneys, including Keller Postman, valuable data. Jury reactions, damage assessments, and evidentiary rulings from these trials are feeding directly into current settlement negotiations.
| Bellwether Trial Factor | Status in 2026 |
|---|---|
| Purpose | Gauge jury sentiment and damages |
| Outcome Impact | Directly influences global settlement value |
| Plaintiff Advantage | Juries historically sympathetic to child ASD diagnoses |
| Defendant Strategy | Push for lower settlement tiers pre-verdict |
| Keller Postman Role | Active in bellwether case selection and preparation |
The specific results of 2026 bellwether proceedings are being monitored closely. Any plaintiff verdict in the eight-figure range would apply significant pressure on defendants to settle the remaining 100,000-plus cases rather than risk further exposure.
Tylenol Autism MDL Settlement 2026
A global settlement in the Tylenol autism MDL for 2026 has not been officially announced as of this writing, but settlement discussions are actively underway. This is the phase where the real money starts moving.
In large MDLs, global settlements typically come after bellwether trials demonstrate what juries will award. That process is happening now. Defendants want to cap their liability. Plaintiffs want fair compensation without waiting another three to five years for individual trials.
Keller Postman has experience with exactly this type of high-stakes MDL negotiation. Their attorneys understand how to apply pressure at the right moment.
| Settlement Outlook | Detail |
|---|---|
| Official Settlement | Not finalized as of 2026 |
| Negotiation Status | Active discussions between parties |
| Expected Timeline | Late 2026 or 2027 announcement |
| Precedent Cases | Roundup, talcum powder MDL settlements |
| Total Estimated Fund | Projected in the billions range |
Comparable mass torts offer a useful baseline. The Roundup glyphosate MDL settled for roughly $11 billion. The talcum powder MDL involved billions more. The Tylenol autism MDL, with 100,000-plus plaintiffs, could reach a similar scale once a global resolution is agreed upon.
Key Takeaway: No official Tylenol autism MDL settlement has been announced in 2026, but active negotiations and bellwether outcomes are pushing both sides closer to a global deal.
Who Qualifies for the Tylenol Autism Lawsuit?
You qualify for the Tylenol autism lawsuit if you took Tylenol or generic acetaminophen products during pregnancy and your child was later diagnosed with autism spectrum disorder or ADHD. Those are the two core requirements, but additional factors affect the strength of your claim.
The more evidence you have of regular Tylenol use during pregnancy, and the earlier your child’s diagnosis, the stronger your case. Documented medical records help significantly.
Here is a breakdown of the eligibility criteria:
| Eligibility Factor | Requirement |
|---|---|
| Product Used | Tylenol or any acetaminophen product |
| Timing of Use | During pregnancy (any trimester) |
| Duration of Use | Preferably more than one week of use |
| Child’s Diagnosis | Autism Spectrum Disorder (ASD) or ADHD |
| Diagnosis Timing | Generally before age 18 |
| Supporting Evidence | Medical records, pharmacy records, receipts |
| Statute of Limitations | Varies by state; most within 2 to 3 years of diagnosis |
You do not need to remember the exact brand. Store-brand acetaminophen from Walmart, CVS, Walgreens, or Target counts equally. The chemical is the same regardless of the label on the bottle.
One important note: you do not need to have a “perfect” case to file. Many plaintiffs have limited documentation and still have valid claims. That is what attorneys evaluate during the intake process.
Tylenol Prenatal Exposure Lawsuit Eligibility
Prenatal exposure is the central legal trigger for this lawsuit. Specifically, the claim is based on a mother’s use of acetaminophen during pregnancy, not post-birth exposure. If you took Tylenol while pregnant, that qualifies as prenatal exposure under this litigation.
The timing and duration of that exposure matter. Studies that formed the scientific basis of this lawsuit found stronger associations with prolonged use rather than a single dose for a headache. However, even moderate use during pregnancy can form the basis of a valid legal claim.
Courts have recognized that establishing exact dosage is difficult after the fact. Plaintiffs are not expected to produce pharmacy receipts for every Tylenol pill taken a decade ago. Medical records showing Tylenol was recommended or prescribed during pregnancy can carry significant weight.
| Prenatal Exposure Factors | Detail |
|---|---|
| First Trimester Use | Strongest association in some studies |
| Second Trimester Use | Included in most claims |
| Third Trimester Use | Also included |
| Duration Threshold | Prolonged use strengthens claim; short use still valid |
| Documentation | OB records, medical notes, prescriptions |
| Generic Brand Coverage | Yes, all acetaminophen products covered |
If your OB-GYN recommended Tylenol during pregnancy, as many do for pain or fever management, that is relevant evidence. That note in your medical file is exactly the kind of documentation that strengthens a prenatal exposure claim.
Tylenol ADHD Lawsuit Eligibility
The Tylenol lawsuit covers ADHD diagnoses as well as autism. If your child was diagnosed with attention deficit hyperactivity disorder rather than autism, you may still qualify to file a claim as part of MDL 3043. ADHD is treated as a separate injury category within the litigation.
The science behind ADHD claims is strong. The JAMA Pediatrics study and other research specifically identified elevated ADHD rates among children with high prenatal acetaminophen exposure. Courts have treated ADHD as a distinct and compensable neurodevelopmental injury in this MDL.
ADHD claims may have slightly different payout expectations than autism claims due to the differences in severity and lifetime impact. But they are absolutely valid claims and are actively being pursued.
| ADHD Claim Requirements | Detail |
|---|---|
| Eligible Diagnosis | ADHD (any subtype) |
| Prenatal Exposure Required | Yes, mother’s use of acetaminophen |
| Diagnosis Timing | Before filing deadline |
| Documentation Needed | Child’s ADHD diagnosis records, medical history |
| Relative Payout | Potentially lower than severe ASD but still significant |
| Filing Process | Same as autism claims within MDL 3043 |
Key Takeaway: Both autism and ADHD diagnoses qualify under MDL 3043, and ADHD plaintiffs should not assume their claims are weaker or less worth filing.
Tylenol Autism Lawsuit Payout Per Person
The payout per person in the Tylenol autism lawsuit has not been officially set, but estimates based on comparable MDL settlements and the severity of claims suggest individual plaintiffs could receive anywhere from $50,000 to over $500,000 depending on their case. These are not guaranteed figures. They reflect the range seen in similar mass torts.
The way MDL settlements work is through a points or tier system. Plaintiffs with more severe diagnoses, stronger documentation, and earlier filing dates typically receive larger shares of a global settlement fund. A child with severe nonverbal autism will likely be placed in a higher compensation tier than one with a mild ADHD diagnosis.
Attorney fees in mass tort cases typically run at 33 to 40 percent contingency. That comes out of your recovery, not out of pocket.
| Estimated Payout Tiers | Description | Estimated Range |
|---|---|---|
| Tier 1 (Highest) | Severe ASD, strong documentation | $300,000 to $500,000+ |
| Tier 2 | Moderate ASD or severe ADHD | $100,000 to $300,000 |
| Tier 3 | Mild ASD or moderate ADHD | $50,000 to $100,000 |
| Tier 4 (Lowest) | ADHD with limited documentation | $20,000 to $50,000 |
| Attorney Fees | Contingency (typically 33 to 40%) | Deducted from payout |
These figures are projections based on the structure of similar MDL settlements. The actual numbers depend entirely on the final global settlement agreement between plaintiffs’ counsel and defendants.
How Much Will the Tylenol Lawsuit Pay Out?
The total payout for the Tylenol autism MDL is expected to be in the billions of dollars once a global settlement is reached. Individual plaintiff recovery will depend on their tier placement within the settlement structure, the strength of their evidence, and the total number of qualifying claimants.
Drawing a comparison: the Roundup cancer MDL settled for approximately $11 billion. The 3M earplug MDL settled for $6 billion. The Tylenol autism MDL with over 100,000 plaintiffs and high-severity injuries like autism could reach a similar or higher aggregate figure.
But here is the critical math most people miss: a $10 billion fund split among 100,000 plaintiffs averages $100,000 per person before fees. The tier system means some get significantly more and others get less than that average.
| Total Settlement Comparison | Case | Settlement Amount |
|---|---|---|
| Roundup Glyphosate MDL | Bayer/Monsanto | ~$11 billion |
| 3M Earplug MDL | 3M Company | ~$6 billion |
| Talcum Powder MDL | Johnson and Johnson | Ongoing, billions |
| Tylenol Autism MDL 3043 | J&J and retailers | TBD; projected billions |
The more plaintiffs who file legitimate claims before the deadline, the larger the overall fund needs to be. That is another reason why filing sooner rather than later matters.
Tylenol ADHD Lawsuit Settlement Amount
The settlement amount for ADHD-specific claims in the Tylenol lawsuit is expected to be lower on a per-plaintiff basis compared to severe autism claims, but still meaningful. ADHD is considered a compensable injury under MDL 3043, and plaintiffs with ADHD diagnoses are actively included in settlement negotiations.
Think of the payout structure like insurance tiers. You file a claim for what happened to your family. The settlement allocation process then evaluates severity, documentation, and corroborating evidence to place you in a compensation bracket. ADHD without comorbid autism typically lands in a lower bracket, but that bracket can still represent tens of thousands of dollars.
The ADHD-specific scientific evidence is actually quite strong. Studies showing a dose-response relationship between prenatal acetaminophen and ADHD risk have held up to peer review. That gives ADHD plaintiffs real legal standing.
| ADHD Claim Settlement Estimate | Detail |
|---|---|
| Estimated Individual Range | $20,000 to $150,000 |
| Key Factors | Severity, duration of exposure, documentation |
| Scientific Backing | JAMA Pediatrics and multiple cohort studies |
| Filing Deadline | 2026 cutoff approaching |
| Processing Timeline | Post-global settlement allocation |
If you have an ADHD claim, do not write it off as not worth pursuing. Even at the lower end of payout estimates, these amounts represent real compensation for real harm.
Key Takeaway: ADHD plaintiffs face lower average payouts than autism plaintiffs, but the Tylenol MDL still offers meaningful compensation for qualifying families with documented prenatal exposure.
Keller Postman Law Firm Tylenol Case Status
Keller Postman remains one of the most active plaintiffs’ firms in MDL 3043 as of 2026. The firm has filed tens of thousands of individual plaintiff cases and maintains a significant presence in ongoing litigation strategy and settlement negotiations.
The firm is known for its work in large-scale digital privacy and mass tort litigation. Their approach in the Tylenol MDL has been aggressive from the start: filing high volumes of cases, challenging defendant motions, and preparing clients for the long haul. That patience is paying off in 2026 as settlement discussions intensify.
Keller Postman clients should have access to a case status portal where they can track developments. The firm has been communicating regularly with plaintiffs about what the 2026 developments mean for their individual cases.
| Keller Postman in MDL 3043 | Detail |
|---|---|
| Role | Lead plaintiffs’ counsel |
| Cases Filed | Tens of thousands |
| Case Strategy | Aggressive filing, appellate pursuit, settlement pressure |
| Client Communication | Regular updates via portal and direct contact |
| Fee Structure | Contingency (no upfront costs) |
| Headquarters | Chicago, Illinois |
If you are already a Keller Postman client and have not heard from them recently, reach out directly through their official client portal. Case developments in 2026 are moving fast, and staying informed is important.
Tylenol Lawsuit Deadline 2026
The filing deadline for the Tylenol autism lawsuit varies depending on your state’s statute of limitations, but many claimants face deadlines in 2026 that could permanently bar their right to participate. Missing this window means missing your shot at compensation entirely.
Statutes of limitations in product liability cases typically run two to three years from the date you discovered or should have discovered the connection between the product and your child’s diagnosis. For many families who have been following this lawsuit since major media coverage began in 2022 and 2023, that clock has been ticking.
There is no single universal deadline for the entire MDL, but individual state law deadlines apply. States like California, Florida, Texas, and New York have different cutoff dates. Your attorney calculates which deadline applies to your specific situation.
| State | Statute of Limitations |
|---|---|
| California | 2 years from discovery |
| Florida | 4 years from discovery |
| New York | 3 years from discovery |
| Texas | 2 years from discovery |
| Illinois | 2 years from discovery |
| Ohio | 2 years from discovery |
Act now if you think you qualify. The “discovery rule” generally means the clock started when you first learned that Tylenol might be linked to your child’s diagnosis. For many people, that was sometime in 2022 or 2023. The math on those deadlines is urgent.
Keller Postman Tylenol Claim Filing Process
Filing a Tylenol autism claim with Keller Postman involves a straightforward intake process that starts with a free case evaluation. You do not pay anything to get started, and you do not owe anything unless the case resolves in your favor.
The process has a few clear steps. Here is what to expect:
Step 1: Initial Consultation
You contact the firm, provide basic information about your pregnancy, your Tylenol use, and your child’s diagnosis. This takes about 15 to 30 minutes.
Step 2: Intake and Documentation
The firm collects your child’s medical records confirming the ASD or ADHD diagnosis. They gather any documentation you have of Tylenol use during pregnancy.
Step 3: Case Filing
Your individual case is filed within MDL 3043. You become an official plaintiff with your own case number.
Step 4: Plaintiff Fact Sheet
You complete a Plaintiff Fact Sheet (PFS), a standard MDL document detailing your exposure history and your child’s diagnosis timeline.
Step 5: Ongoing Communication
You receive updates as the MDL progresses. Keller Postman manages the litigation; you wait for settlement developments or trial scheduling.
| Filing Process Step | Action Required |
|---|---|
| Step 1 | Free case evaluation (phone or online) |
| Step 2 | Submit medical records and documentation |
| Step 3 | Case filed in MDL 3043 |
| Step 4 | Complete Plaintiff Fact Sheet |
| Step 5 | Monitor case updates through firm portal |
The entire process costs you nothing upfront. Contingency fee agreements mean the firm gets paid only if you win or settle.
Is the Tylenol Autism Lawsuit Still Active?
Yes, the Tylenol autism lawsuit is absolutely still active in 2026. Despite early setbacks including a controversial Daubert ruling in 2023, the MDL has survived appellate review and continues to move forward. Thousands of cases remain in active litigation.
The concern that this lawsuit “died” after the 2023 Daubert ruling was premature. Plaintiffs’ attorneys, including Keller Postman, adjusted their expert strategies. Appellate courts have given the litigation a viable path forward.
Defendants have not won. No final ruling has thrown out all plaintiff claims. The case is alive, active, and moving toward resolution.
| Case Vitality Indicator | Status |
|---|---|
| MDL 3043 Status | Active |
| Keller Postman Filing New Cases | Yes |
| Settlement Talks Ongoing | Yes |
| Bellwether Trials | In progress |
| Appellate Rulings Favorable | Partially |
| New Plaintiffs Accepted | Yes, with deadline caveats |
If you heard this lawsuit was over, that information was wrong. The only thing that ended was a specific expert witness ruling. The litigation itself is very much open, and families are still joining every day.
Key Takeaway: The Tylenol autism lawsuit is still active in 2026, Keller Postman is still accepting clients, and settlement negotiations are at their most serious stage yet.
Frequently Asked Questions
What is the current status of the Keller Postman Tylenol lawsuit in 2026?
The Keller Postman Tylenol lawsuit is active in 2026, with MDL 3043 in settlement negotiation phase following bellwether trial proceedings.
Keller Postman continues to file new cases and push for a global resolution on behalf of plaintiff families.
No official settlement has been finalized, but serious negotiations are underway and a resolution is expected in late 2026 or 2027.
Who qualifies to file a claim in the Tylenol autism lawsuit?
You qualify if your mother used Tylenol or acetaminophen during pregnancy and you were later diagnosed with autism spectrum disorder or ADHD.
Documentation of prenatal exposure and a formal ASD or ADHD diagnosis are the two primary requirements.
Even limited documentation is worth evaluating with an attorney, as many plaintiffs have incomplete records and still have valid claims.
How much money could I receive from the Tylenol autism settlement?
Individual payouts are estimated between $20,000 and $500,000 or more, depending on your injury tier and documentation strength.
Severe autism diagnoses with strong exposure evidence tend to land in higher payout tiers, while ADHD claims typically fall in the lower to middle range.
Attorney fees of roughly 33 to 40 percent will be deducted from your settlement amount as part of the contingency agreement.
What is the filing deadline for the Tylenol lawsuit in 2026?
Filing deadlines vary by state, but many claimants face statutes of limitations that expire in 2026 based on when they first learned of the Tylenol-autism connection.
States like California and Texas have two-year windows from discovery, meaning families who became aware of the link in 2023 or 2024 may be approaching their cutoff.
Consulting with a firm like Keller Postman as soon as possible is the only way to confirm your specific deadline.
Is it too late to join the Keller Postman Tylenol lawsuit?
It is not too late for most claimants, but time is shortening fast and the 2026 window is closing for many state-specific deadlines.
Keller Postman is still accepting new clients and evaluating cases at no upfront cost.
If you believe you qualify, the right move is to start the intake process immediately rather than wait for the settlement announcement.
What This Means for Families Right Now
The Keller Postman Tylenol lawsuit update for 2026 tells one clear story: this case is alive, serious, and moving toward a resolution that could deliver real money to real families.
If you used Tylenol while pregnant and your child has an autism or ADHD diagnosis, you have a window to file. That window is measured in months for many people, not years.
Start the intake process now. Gather your medical records. Contact Keller Postman or another MDL attorney. Do not wait for the settlement announcement to act, because by then the filing period may already be closed.
